95556-7

LOINC 2.82

Adrenal cancer risk assessment and urine steroid fractions panel

Adrenal ca risk assess+ur steroid Pnl

Definition

  • A risk assessment based on patient clinical data combined with biochemical steroid results to assess the probability of a malignant adrenal cortical carcinoma (ACC) or other malignancy (e.g. sarcoma, lymphoma) versus the probability of a benign mass (e.g. adenoma, myelolipoma, cyst). Clinical biomarkers may include age at diagnosis, gender, mode of discovery, hormonal status (e.g. overproduction), tumor diameter, and density of the tumor by CT.

Component

  • Adrenal cancer risk assessment & urine steroid fractions panel

Specimen / system

  • ^Patient

Class

  • PANEL.CHEM

Property

  • -

Scale

  • -

Related names

  • Adrenal ca risk assess+ur steroid Pnl; Adrnl; CAH; Chemistry; Congenital adrenal hyperplasia; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Steroid Fract Pnl

Index terms

  • Adrenal ca risk assess+ur steroid Pnl
  • Adrenal cancer risk assessment & urine steroid fractions panel
  • Adrnl
  • CAH
  • Chemistry
  • Congenital adrenal hyperplasia
  • Frac
  • Fract
  • Fraction
  • Fractionated
  • Fractionation
  • Pan
  • PANEL.CHEMISTRY
  • Panl
  • Pnl
  • Steroid Fract Pnl